Related Experiment Videos
Phenotypic heterogeneity and aberrant markers expression in T-cell leukemia
O Babusíková1, M Glasová, E Koníková
1Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovakia.
Neoplasma
|August 26, 1998
Summary
Flow cytometry immunophenotyping of T-acute lymphoblastic leukemia (T-ALL) revealed significant marker heterogeneity. A simplified classification based on CD3 expression identified two main T-ALL phenotypes, aiding in diagnosis.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Accurate lineage assessment in T-acute lymphoblastic leukemia (T-ALL) requires robust immunophenotyping.
- Existing classification schemes struggle with the heterogeneity of T-cell differentiation markers in T-ALL.
Purpose of the Study:
- To evaluate surface and intracellular immunophenotyping in 34 T-ALL cases.
- To develop a simplified classification system for T-ALL phenotypes.
- To investigate atypical/aberrant T-cell phenotypes and their potential diagnostic significance.
Main Methods:
- Flow cytometry was used for surface membrane and intracellular immunophenotyping.
- Analysis included 34 T-ALL cases, assessing CD3 expression and other lineage-specific markers.
- Quantitative immunofluorescence was explored as a diagnostic tool.
Main Results:
- Significant heterogeneity in T-cell differentiation markers was observed, challenging existing classifications.
- A simplified T-ALL classification based on CD3 expression yielded two main groups: immature (Stage I, 79%) and mature (Stage II, 21%).
- Atypical markers, including CD10, CD34, and CD13, were identified in T-ALL cases, suggesting abnormal rather than immature phenotypes.
Conclusions:
- A simplified CD3-based classification effectively categorizes T-ALL phenotypes.
- Atypical markers coexpressed across differentiation stages may indicate abnormal phenotypes with prognostic implications.
- Quantitative immunofluorescence offers valuable diagnostic insights in T-ALL.